- Global Pharma News & Resources

Impact of Covid-19 on Anxiety Disorder and Depression Treatment Market Expected to Witness the Highest Growth 2027 with Top Key Players Johnson & Johnson Inc., Pfizer, GlaxoSmithKline plc, etc

: New York, United States, 19-July-2020, (Via WiredRelease), (Reports and Data) – The Global Anxiety Disorder and Depression Treatment Market is forecast to reach USD18.90 Billion by 2026, according to a new report by Reports and Data. There has been a continued rise in the rate of depression and anxiety in the global healthcare scenario. Such a rise in the incidence rate of depression and anxiety has resulted in focusing on the global healthcare scenario and reduce the incidence rate of such mental healthcare condition. In the year 2018, more than 300 million individuals of all ages were suffering from depression in the global scenario. There have been 800,000 incidents of suicides in the same year, the reason behind which has been primarily, depression and anxiety disorders. Such a rise in the incidence of rate of depression and anxiety are one of the major factors driving the global Anxiety Disorder and Depression Treatment Market.

Globally, incidences of depression and mental health are continuously increasing in the elderly population. This population is prone to mental health issues like dementia, phobia and anxiety disorders. Hence, the increase in the graying population is also contributing to the rising demand for antidepressants and therapies to treat the mental health condition during the forecast period.

Get Sample Copy with TOC of the Report to understand the structure of the complete report @

The COVID-19 impact:
Covid-19’s spread has affected manufacturing and construction activities worldwide. Logistic limitations and reconsiderations of the raw material requirements are becoming a problem for producers. The producers have relied on derived demand as an intermediate commodity to rationalize production. The pandemic’s economic impact on companies and financial markets is also not favorable. Stock market volatility and decreasing global growth are anticipated, which will affect the market.  The market has experienced a downturn over the weeks, which may continue over the next few months. The Asia Pacific is the most affected region by this pandemic, with China at the center of the outbreak. Most initiatives in multiple countries have changed to a temporary halt. Development, as well as supply, is put on hold, creating losses for suppliers, dealers and customers alike.

Key participants include

Johnson & Johnson, Inc., Pfizer, GlaxoSmithKline plc., Lundbeck A/S, Inc., Sanofi- Aventis, Merck & Company, AstraZeneca PLC., Forest Laboratories, Eli Lilly and Company, Bristol-Myers Squibb Company among.

Any Query or Discount? Ask our Expert @

For the purpose of this report, Reports and Data have segmented into the global Anxiety Disorder and Depression Treatment market on the basis of type, propellants, application, and region:

Drug class Outlook (Revenue, USD Billion; 2016-2026)

Selective Serotonin Reuptake Inhibitors (SSRIs)Antidepressant DrugsTricyclic Antidepressants (TCAs)Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)AnticonvulsantsBeta-BlockersOthers

Therapies Outlook (Revenue, USD Billion; 2016-2026)

Electroconvulsive Therapy (ECT)Cognitive Behavior Therapy (CBT)PsychotherapyDeep Brain StimulationTranscranial Magnetic Stimulation (TMS)Cranial electrotherapy stimulation (CES)

Devices Outlook (Revenue, USD Billion; 2016-2026)

Cranial electrotherapy stimulatorFisher-Wallace stimulator market

Application Outlook (Revenue, USD Billion; 2016-2026)

PhobiaMajor Depressive DisorderObsessive Compulsive Disorder (OCD)Post-traumatic stress disorderOthers

Regional Outlook (Revenue, USD Million; 2017-2027)

North America





Asia Pacific





Latin America


Purchase this report @

About Us:
Our in-house experts assist our clients with advice based on their proficiency in the market that helps them in creating a compendious database for the clients. Our team offers expert insights to clients to guide them through their business ventures. We put in rigorous efforts to keep our clientele satisfied and focus on fulfilling their demands to make sure that the end-product is what they desire. We excel in diverse fields of the market and with our services extending to competitive analysis, research and development analysis, and demand estimation among others, we can help you invest your funds in the most beneficial areas for research and development.

Contact Us:
John Watson
Head of Business Development
Reports and Data | Web:
Direct Line: +1-212-710-1370

This content has been published by MARKETYSERS GLOBAL CONSULTING LLP company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at

Editor Details

Last Updated: 20-Jul-2020